New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 18, 2014
05:52 EDTSAGESage Therapeutics 5M share IPO priced at $18.00
The deal priced at the high end of the revised $17.00-$18.00 range. JPMorgan and Goldman acted as joint book running managers for the offering.
News For SAGE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 23, 2015
08:36 EDTSAGESAGE Therapeutics price target raised to $91 from $80 at Goldman
Goldman has increased confidence in SAGE Therapeutics' SAGE-547 following positive PPD data released a few weeks ago. The firm raised its price target on Buy rated SAGE to $91 from $80 and said recent weakness from the lock-up expiration provides a buying opportunity.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use